Developing National Systems: Spain as a Model

    Research output: Contribution to journalArticleResearchpeer-review

    4 Citations (Scopus)

    Abstract

    The development of a national system for drug monitoring in Spain is described. The pharmaceutical market in many European countries is very different from that in other regions (eg, the Nordic Countries or the UK) with a tradition in drug surveillance activities. This paper focuses on the coordinated development of drug information and drug surveillance activities in a model country where a rational drug policy is urgently needed. © 1985, Drug Information Association. All rights reserved.
    Original languageEnglish
    Pages (from-to)351-355
    JournalTherapeutic Innovation & Regulatory Science
    Volume19
    Issue number3
    DOIs
    Publication statusPublished - 1 Jan 1985

    Keywords

    • Drug selection
    • Drug surveillance
    • Spontaneous reporting

    Fingerprint

    Dive into the research topics of 'Developing National Systems: Spain as a Model'. Together they form a unique fingerprint.

    Cite this